Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerDNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, milker's nodule, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, vaccinia, viral infectious diseaseRecruitingPhase 22026-06-04NCT06463665

2 results · Page 1 of 1

Swipe the table sideways for more columns.

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BioResearch PartnerHialeahUnited States7
Bioresearch PartnerMiamiUnited States4
Brcr Medical Center, Inc.PlantationUnited States2
Clermont Oncology CenterClermontUnited States17
Gabrail Cancer and Research CenterCantonUnited States5
Helios Clinical ResearchFort LauderdaleUnited States2
Inspira Medical Center Mullica HillMullica HillUnited States30
Michigan Hematology and Oncology ConsultantsDearbornUnited States1
Mid Florida Hematology and Oncology CenterOrange CityUnited States23
Oakland Medical GroupFarmington HillsUnited States1
Oncology & Hematology Associates of West BrowardCoral SpringsUnited States3
Pioneer Research Center, LLCBullhead CityUnited States1
Texas Oncology - Austin CentralAustinUnited States1
University of Miami - Sylvester Comprehensive Cancer CenterMiamiUnited States15
World Research LinkBaytownUnited States5